Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.

BACKGROUND: Increased intra-hepatic resistance to portal blood flow is the primary factor leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 (COX-2) in the cirrhotic liver might be a potential target to ameliorate portal hypertension. OBJECTIVE: To verify the ef...

Full description

Bibliographic Details
Main Authors: Jin-Hang Gao, Shi-Lei Wen, Wen-Juan Yang, Yao-Yao Lu, Huan Tong, Zhi-Yin Huang, Zhang-Xu Liu, Cheng-Wei Tang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3724827?pdf=render

Similar Items